3. Lion's Mane Mushroom
The "smart" mushroom — hericenones and erinacines, NGF stimulation, and the new cognitive clinical evidence.
Lion's Mane Mushroom in 1 minute
What does it provide? A unique diterpenoid compound family (hericenones, erinacines) that crosses the blood–brain barrier and stimulates NGF/BDNF expression — a property essentially unique among mushrooms. Additionally, β-glucan immunomodulation and prebiotic microbiome effect.
How much? In the kitchen, 50–150 g fresh fruiting body, 2–3×/week. As a supplement, 500–3000 mg dry dual-extract (fruiting body + mycelium) daily, with meals.
When to avoid? Mushroom allergy, existing bleeding disorder, anticoagulant therapy, 2 weeks before planned surgery, supplement doses during pregnancy and breastfeeding.
Lion's mane mushroom (Chinese: "hou tou gu" — monkey's head mushroom; Japanese: "yamabushitake" — mountain monk mushroom) has been part of East Asian cuisine and healing tradition for more than 1,000 years. Chinese medical records from the Tang dynasty (618–907) describe it as a mushroom "strengthening the five great organs," chiefly indicated for digestive complaints, stomach ulcer, and "spirit strengthening." Buddhist yamabushi monks in the Japanese mountains consumed it ritually during long meditation retreats — by tradition, in support of concentration and spiritual clarity.
Modern research started in 1991, when Kawagishi and a Japanese research group first isolated hericenones A and B in Tetrahedron Letters and showed they could stimulate Nerve Growth Factor (NGF) production in neurons.[1356] The erinacines were then identified in the mycelium — even stronger NGF inducers, and they cross the blood–brain barrier. Mori et al.'s 2009 Japanese RCT in subjects aged 50–80 with mild cognitive impairment showed statistically significant improvement on the Hasegawa scale after 16 weeks of daily 3 g powder dosing — this became lion's mane's "breakthrough" human evidence.[1357] Saitsu et al. in 2019 described a decrease in depression-anxiety scores in menopausal women after 4 weeks of dosing.[1360]
Scientific Background
Hericenones and erinacines are small molecular weight, lipophilic diterpenoids and aromatic compounds that cross the blood–brain barrier — a critical distinguishing property, because most mushroom bioactives (β-glucan, lectins) do not. In vitro and in animal studies, they dose-dependently increase NGF and BDNF mRNA expression in hippocampal and cortical neurons, inhibit τ-protein hyperphosphorylation, and reduce amyloid-β-induced neurotoxicity.[1361] Clinically, this translates to the positive Hasegawa-scale findings of the Mori 2009 RCT, as well as the cognitive improvement seen in mild Alzheimer's patients in the more recent Li et al. 2020 study.[1359][1358]
The β-glucans (mainly β-1,3/1,6-glucans), upon reaching the colon, send modulating signals to the gut-associated immune system via dectin-1 and TLR-2 receptors. Human pilot studies of regular lion's mane consumption have described increases in the relative abundance of Akkermansia muciniphila and Faecalibacterium prausnitzii, along with enhanced butyrate and propionate production.[1362] This complements the direct NGF-stimulating effect via the "gut–brain axis."[1363]
Important: cold-water or ethanol extraction primarily yields the hericenones (fruiting body), while erinacines (mycelium) require different conditions. This is why scientifically grounded preparations contain both the fruiting body and the mycelium in a "dual-extract" format. Cooking (≤ 90 °C, 20–30 minutes) preserves a significant portion of the hericenones; high-temperature roasting (> 180 °C, 15+ minutes), however, degrades them.
- + Healthy fat (extra-virgin olive oil, ghee, butter): hericenones and erinacines are lipophilic — they are better absorbed with fat. The classic "mushrooms sautéed in butter" pattern is also scientifically justified.
- + Omega-3 fatty acids (salmon, walnut, flaxseed): synergistic neuroprotective effect — omega-3 DHA stabilizes membranes, lion's mane stimulates NGF.
- + B-vitamin complex (yeast, eggs, legumes): B12, B6, folate are needed for myelination and neurotransmitter synthesis — together, more complete neurocognitive support.
- + Polyphenol-rich foods (blueberry, green tea, dark chocolate): antioxidant synergy, additive effect on the BDNF signaling pathway.
- + Fiber-rich diet: β-glucan's microbiome effect is more fully expressed in the presence of other fermentable fibers.
- + Lemon juice: drizzled on the fresh fruiting body, useful not only for flavor but also as a vitamin C synergy for stabilizing polyphenols.
- Anticoagulants (warfarin, DOACs — apixaban, rivaroxaban, dabigatran; aspirin, clopidogrel): β-glucans and some triterpenoids show mild antiaggregant effect — high-dose supplement to be avoided, culinary amounts are safe.
- Immunosuppressants (tacrolimus, ciclosporin, chronic-dose corticosteroids): the immunomodulating β-glucan effect can theoretically interfere — after organ transplantation, consult a physician.
- Diabetes medications (insulin, sulfonylureas, metformin): lion's mane has a moderate glucose-lowering effect — risk of hypoglycemia at supplement doses.
- On an empty stomach, in capsule form: moderate stomach irritation possible — always take with meals.
- Consumed at the same time as alcohol: alcohol inhibits BDNF synthesis — cancels out lion's mane's cognitive advantage.
- Mushroom allergy (Basidiomycota): anaphylactic reaction is rare but described — small test serving at first consumption.
- Asthma, atopic dermatitis acute flare: a few case reports described contact-orientated airway reactions to lion's mane spore inhalation (home cultivation). Rare when consumed.
- Active autoimmune disease (SLE, RA, MS) during flare: the direction of immunomodulation is not always clear — consult a rheumatologist for supplement doses.
- 2 weeks before planned surgery: stop high-dose supplement (bleeding risk).
- Pregnancy, breastfeeding: dietary amounts likely safe, but no human safety data for concentrated supplement — avoid.
- Children under 18: trendy "nootropic" use for ADHD or autism treatment is unfounded — no pediatric RCT, no safety data.
- During active Helicobacter pylori infection treatment: theoretical gastric mucosa modulation — start after treatment completion.
Serving: 50–150 g fresh fruiting body per meal, 2–3×/week.
Preparation: Tear fresh lion's mane into smaller pieces by hand (do NOT dice with a knife — the fiber structure preserves texture better this way). In a dry skillet 2–3 minutes until the water releases, then 1–2 tbsp olive oil/butter + salt, 5–7 minutes on medium heat. The classic "crab-like" texture forms this way.
Classic patterns:
- Lion's mane sautéed in butter, with garlic and parsley — simple, mobilizes the hericenones with fat.
- Pasta with lion's mane and parmesan — high protein, enjoyable, easy to portion.
- In soups (miso, mushroom, Japanese dashi) — β-glucans dissolve in water.
- Breakfast scrambled eggs with lion's mane — eggs (choline) + mushroom (hericenone) → neurocognitive synergy breakfast.
- Dried lion's mane powder in soups, smoothies — 1–2 g/day household dosing.
Storage: Fresh, refrigerated, wrapped in paper, max 5 days. Dried in an airtight jar in a dark place, 12 months. Frozen (after pre-sautéing), 6 months.
What not to do: Don't roast above 180 °C for 15+ minutes (hericenone breakdown). Don't eat raw — the chitin matrix is indigestible. Don't mix with other strongly flavored mushrooms (porcini, button), or its delicate "crab-like" character will be lost.
References
[1356] Kawagishi H et al. Hericenones C, D, and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Letters 1991;32(35):4561–4564. . 1991. Link
Experimental chemistry paper describing hericenones C, D and E isolated from the mushroom Hericium erinaceum as stimulators of nerve growth factor (NGF) synthesis.
[1357] Mori K et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009;23(3):367–372. . 2009. Link
A double-blind, parallel-group, placebo-controlled trial was performed on 50- to 80-year-old Japanese men and women diagnosed with mild cognitive impairment in order to examine the efficacy of oral administration of Yamabushitake (Hericium erinaceus), an edible mushroom, for improving cognitive impairment, using a cognitive function scale based on the Revised Hasegawa Dementia Scale (HDS-R). After 2 weeks of preliminary examination, 30 subjects were randomized into two 15-person groups, one of which was given Yamabushitake and the other given a placebo. The subjects of the Yamabushitake group took four 250 mg tablets containing 96\% of Yamabushitake dry powder three times a day for 16 weeks. After termination of the intake, the subjects were observed for the next 4 weeks. At weeks 8, 12 and 16 of the trial, the Yamabushitake group showed significantly increased scores on the cognitive function scale compared with the placebo group. The Yamabushitake group's scores increased with the duration of intake, but at week 4 after the termination of the 16 weeks intake, the scores decreased significantly.
[1358] Saitsu Y et al. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomedical Research 2019;40(4):125–131. . 2019. Link
Randomized, double-blind, placebo-controlled parallel-group trial: participants took a supplement containing Hericium erinaceus fruiting body or placebo for 12 weeks. Cognitive function was assessed by MMSE, Benton visual retention test, and standard verbal paired-associate learning test; by MMSE, oral intake of H. erinaceus significantly improved cognitive function and prevented its deterioration.
[1359] Li IC et al. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Frontiers in Aging Neuroscience 2020;12:155. . 2020. Link
OBJECTIVE: To investigate the efficacy and safety of three H. erinaceus mycelia (EAHE) capsules (350 mg/capsule; containing 5 mg/g erinacine A active ingredient) per day for the treatment of patients with mild Alzheimer's Disease (AD). METHODS: This study comprised a 3-week no-drug screening period, followed by a 49-week double-blind treatment period with 2-parallel groups in which eligible patients were randomized to either three 5 mg/g EAHE mycelia capsules per day or identical appearing placebo capsules. Cognitive assessments, ophthalmic examinations, biomarker collection, and neuroimaging were followed throughout the study period. RESULTS: After 49 weeks of EAHE intervention, a significant decrease in Cognitive Abilities Screening Instrument score was noted in the placebo group, a significant improvement in Mini-Mental State Examination score was observed in the EAHE group and a significant Instrumental Activities of Daily Living score difference were found between the two groups. In addition, EAHE group achieved a significantly better contrast sensitivity when compared to the placebo group. Moreover, only the placebo group observed significantly lowered biomarkers such as calcium, albumin, apolipoprotein E4, hemoglobin, and brain-derived neurotrophic factor and significantly elevated alpha1-antichymotrypsin and amyloid-beta peptide 1-40 over the study period.
[1360] Nagano M et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research 2010;31(4):231–237. . 2010. Link
Hericium erinaceus, a well known edible mushroom, has numerous biological activities. Especially hericenones and erinacines isolated from its fruiting body stimulate nerve growth factor (NGF) synthesis, which expects H. erinaceus to have some effects on brain functions and autonomic nervous system. Herein, we investigated the clinical effects of H. erinaceus on menopause, depression, sleep quality and indefinite complaints, using the Kupperman Menopausal Index (KMI), the Center for Epidemiologic Studies Depression Scale (CES-D), the Pittsburgh Sleep Quality Index (PSQI), and the Indefinite Complaints Index (ICI). Thirty females were randomly assigned to either the H. erinaceus (HE) group or the placebo group and took HE cookies or placebo cookies for 4 weeks. Each of the CES-D and the ICI score after the HE intake was significantly lower than that before. In two terms of the ICI, "insentive" and "palpitatio", each of the mean score of the HE group was significantly lower than the placebo group. "Concentration", "irritating" and "anxious" tended to be lower than the placebo group.
[1361] Friedman M. Chemistry, nutrition, and health-promoting properties of Hericium erinaceus mushroom fruiting bodies and mycelia. J Agric Food Chem 2015;63(32):7108–7123. . 2015. Link
The culinary and medicinal mushroom Hericium erinaceus is widely consumed in Asian countries, but apparently not in the United States, for its nutritional and health benefits. To stimulate broader interest in the reported beneficial properties, this overview surveys and consolidates the widely scattered literature on the chemistry (isolation and structural characterization) of polysaccharides and secondary metabolites such as erinacines, hericerins, hericenones, resorcinols, steroids, mono- and diterpenes, and volatile aroma compounds, nutritional composition, food and industrial uses, and exceptional nutritional and health-promoting aspects of H. erinaceus. The reported health-promoting properties of the mushroom fruit bodies, mycelia, and bioactive pure compounds include antibiotic, anticarcinogenic, antidiabetic, antifatigue, antihypertensive, antihyperlipodemic, antisenescence, cardioprotective, hepatoprotective, nephroprotective, and neuroprotective properties and improvement of anxiety, cognitive function, and depression. The described anti-inflammatory, antioxidative, and immunostimulating properties in cells, animals, and humans seem to be responsible for the multiple health-promoting properties. A wide range of research advances and techniques are described and evaluated. The collated information and suggestion for further research might facilitate and guide further studies to optimize the use of the whole mushrooms and about 70 characterized actual and potential bioactive secondary metabolites to help prevent or treat human chronic, cognitive, and neurological diseases.
[1362] Wang M et al. Effects of polysaccharides from Hericium erinaceus on gut microbiota. Carbohydr Polym 2019;217:30–38. . 2019.
Study on the effects of polysaccharides from Hericium erinaceus on the gut microbiota.
[1363] Spelman K et al. Neurological activity of Lion's mane (Hericium erinaceus). J Restor Med 2017;6(1):19–26. . 2017.
Review article on the neurological activity of Lion's mane (Hericium erinaceus).